SAFETY OF AMIODARONE USAGE IN PATIENTS WITH WOLFF-PARKINSON-WHITE SYNDROME AND ATRIAL FIBRILLATION
Amiodarone is one of the basic antiarrhytmic drugs for atrial fibrillation treatment. However application of amiodarone in patients with atrial fibrillation and Wolff-Parkinson-White syndrome can induce ventricular fibrillation. Amiodarone usage in these patients should be accompanied by readiness f...
| Glavni autori: | , , |
|---|---|
| Format: | Članak |
| Jezik: | English |
| Izdano: |
Столичная издательская компания
2016-01-01
|
| Serija: | Рациональная фармакотерапия в кардиологии |
| Teme: | |
| Online pristup: | https://www.rpcardio.online/jour/article/view/879 |